TL;DR
Get comfort and care essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A MedPage Today opinion by Hana Kahleova argues that antibiotic use in food animals is an upstream contributor to drug resistance seen in clinics. It cites the decline in colistin resistance after China banned its use as a feed additive, while calling for more attention to farm policy, food purchasing and demand. The article is commentary, not a new study or independent investigation.
Hana Kahleova, a physician writing in a MedPage Today opinion article published October 4, argues that clinicians treating drug-resistant infections should pay more attention to antibiotic use in food animals, not only prescribing in hospitals and clinics. Her central example is China’s 2017 ban on colistin as a feed additive, after which, she says, resistance to the drug fell in animals and people.
Kahleova says roughly 70% of antibiotics considered important to human medicine in the United States are sold for use in food animals. She argues that much of this use is preventive or production-related rather than treatment for sick animals, and links it to crowded conditions in industrial meat production. The percentage and characterization are presented in her opinion article; the supplied material does not include the underlying data or a separate assessment of the figures.
The article describes resistance moving beyond farms through meat, water, dust, workers and manure, eventually contributing to organisms or resistance genes found in human infections. It points to colistin, a drug often reserved for difficult infections, and the spread of the transferable mcr-1 resistance gene after colistin was used as a growth promoter on Chinese pig farms. Kahleova says the gene appeared in patient samples on multiple continents within a few years.
According to the article, China banned colistin as a feed additive in 2017, followed by measurable decreases in colistin resistance in animals and people. Kahleova calls this a real-world example of policy changing resistance trends, rather than a result of a clinical prescribing intervention. The supplied report does not provide the study details, effect sizes or citations needed to independently evaluate that claim.
Resistance Begins Beyond the Clinic
The argument matters to patients and clinicians because resistance can limit treatment options, while the sources of selection pressure may lie outside a hospital’s prescribing system. If antibiotic use in agriculture contributes to resistance reaching people, then stewardship focused only on prescriptions may address part of the problem while leaving other routes untouched.
Kahleova cites estimates that drug-resistant infections kill about 35,000 people annually in the United States and a Lancet forecast of roughly 39 million deaths globally from resistant infections between now and 2050. Those figures describe separate measures and time frames: the U.S. annual estimate and a global projection extending to 2050. They provide scale, but do not by themselves establish how much resistance is caused by food-animal use.
The policy example also has practical implications. A restriction on a particular agricultural use may help preserve a drug’s effectiveness, according to Kahleova’s account. She argues that clinicians can support farm-level rules through professional societies and can raise food choices with patients or review institutional food purchasing. Those steps would complement, not replace, appropriate veterinary treatment or clinical antibiotic stewardship.
As an affiliate, we earn on qualifying purchases.
The Colistin Policy Example
The article distinguishes routine preventive use from treating animals that are genuinely sick. It says the World Health Organization has urged farmers to stop routine preventive antibiotic use in animals that are not ill, while clarifying that this is not a call to eliminate veterinary antibiotics. The supplied source does not provide the WHO document’s date or full wording.
Kahleova frames the farm-to-clinic link as an upstream stewardship issue: bacteria and resistance genes can travel from agricultural settings into human environments and infections. The colistin example serves as her main illustration of policy affecting resistance. She says the decline after China’s 2017 ban was observed in both animals and people, but the original opinion text as supplied does not detail the evidence, timing of measurements or other factors that may have influenced the change.
The piece also cites a projection that livestock antibiotic use is on track to rise by nearly one-third by 2040. It does not specify in the supplied material the projection’s baseline year, geographic coverage or measurement method. The claim should therefore be read as a reported projection, not a measured increase already observed.
antibiotic residue testing in meat
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence and Causation Still Need Detail
The source is an opinion article, not a newly published research study. Although it describes resistance falling after China’s colistin feed-additive ban, the supplied text does not identify the studies, data sets, size of the decline or methods used to separate the policy’s effect from other changes. The example supports Kahleova’s argument as presented, but readers cannot assess the full causal evidence from this material alone.
It is also unclear from the source how much of the resistance burden in human patients can be attributed specifically to food-animal antibiotic use, compared with antibiotic use in human medicine and other environmental sources. The estimates on U.S. antibiotic sales and projected livestock use lack methodological detail in the supplied text. No new government action, clinical guideline or formal policy proposal is announced in the article.
As an affiliate, we earn on qualifying purchases.
Policy and Purchasing Are Proposed Levers
Kahleova urges clinicians to support targeted farm-level restrictions through professional societies, while maintaining access to antibiotics for animals that need treatment. The article does not name a pending rule, legislative timetable or agency decision, so no specific policy milestone is established.
She also recommends discussing plant-forward diets with patients and examining hospital food-service contracts as ways to reduce demand for meat produced with routine antibiotic use. These are proposals in the opinion piece, not reported institutional changes. The next developments to watch are whether professional groups or health systems adopt such measures and whether further research or surveillance clarifies the contribution of agricultural antibiotic use to resistance in human infections.
farm antibiotic residue detection kits
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the news in this article?
Hana Kahleova’s opinion article argues that routine antibiotic use in food animals should be treated as an upstream part of the drug-resistance problem clinicians face. It highlights China’s 2017 colistin feed-additive ban as an example that, she says, was followed by lower resistance in animals and people.
Does the article say veterinary antibiotics should be eliminated?
No. Kahleova says animals that are genuinely sick still need treatment. Her argument is directed at routine preventive use in animals that are not ill, rather than all veterinary antibiotic use.
What is the mcr-1 gene?
The article describes mcr-1 as a transferable colistin-resistance gene. It says the gene emerged in connection with colistin use on Chinese pig farms and later appeared in patient isolates in multiple countries. The supplied material does not give further technical detail.
Does the source prove that farm antibiotic use causes resistant infections?
The article argues that resistance can travel from farms to people and cites the colistin example, but it is an opinion piece rather than a new study. The supplied text does not include enough underlying data to quantify agriculture’s contribution or independently evaluate the causal evidence.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
